...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Epigenetics market size
7
Jan 16, 2024 12:18PM
6
Jan 16, 2024 02:18PM
1
Jan 16, 2024 07:41PM
2
Jan 22, 2024 01:01PM

It is on the expert market and therefore bids/asks are not published is my understanding.

3
Jan 25, 2024 11:48AM
Share
New Message
Please login to post a reply